Aethlon Medical (AEMD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Vernon Bernardino from H.C. Wainwright remains neutral on the stock and has a $23.00 price target.
Vernon Bernardino’s Buy rating for Aethlon Medical (AEMD) is primarily based on the promising developments in the company’s oncology clinical program. A key factor is the company’s receipt of clearance from the Drug Controller General of India to conduct a Phase 1 clinical trial with the Hemopurifier in patients suffering from solid tumors. This study is seen as an important step in advancing the Hemopurifier as a potential treatment option across various types of tumors. Furthermore, the Hemopurifier’s unique design, which allows it to capture circulating viruses, bacterial toxins, and cancer-promoting exosomes, is highly regarded.
The planned oncology trial, which aims to evaluate the Hemopurifier in a diverse patient pool, has also been cited as a positive factor. Positive early results, such as high rates of tumor exosome removal, could lead to a reevaluation of the current models. In addition, the Hemopurifier’s FDA Breakthrough Device designation in the U.S is seen as an encouraging sign. Despite the expected increase in operating expenses and the need for additional financing due to the expansion of clinical programs, the overall outlook remains positive. This, coupled with the adjusted price target of $23, underpins the Buy rating given by Mr. Bernardino.
According to TipRanks, Bernardino is a 4-star analyst with an average return of 4.8% and a 25.20% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Cassava Sciences, Citius Pharmaceuticals, and Candel Therapeutics.
See today’s best-performing stocks on TipRanks >>
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Aethlon Medical (AEMD) Company Description:
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
Read More on AEMD:
